Literature DB >> 17393111

Relationship between the changes of VEGF level and dendritic cells in peripheral blood of patients with hepatocellular carcinoma after transcatheter arterial chemoembolization.

Jinwen Liu1, Jilin Yi.   

Abstract

In order to investigate the relationship between the VEGF level and the counts of dendritic cells (DCs) in peripheral blood of patients with hepatocellular carcinoma (HCC) before and after transcatheter arterial chemoembolization (TACE), the peripheral blood was obtained from 37 patients with HCC who treated by TACE. The blood was obtained on the day before TACE, the first day, the 7th day and the 15th day after TACE respectively. The counts of DCs were quantified by flow cytometry. The plasma VEGF level was measured by ELESA kit. It was shown after TACE, the counts of DCs in peripheral blood were decreased significantly (P<0.05), and the VEGF level in peripheral blood was increased significantly (P<0.05). The counts of DCs in peripheral blood had an inverse correlation with the plasma VEGF level (r=-0.57, P<0.05) after TACE. It was concluded that in patients with HCC after TACE, the increased plasma VEGF level appeared to have the effect to suppress the maturation of DCs, which may contribute to reduction of the body's anti-tumor immunity effect, with a consequence of recur and metastasis of tumor.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17393111     DOI: 10.1007/s11596-007-0117-y

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  9 in total

1.  Prognostic significances of tumor-infiltrating S-100 positive dendritic cells and lymphocytes in patients with hepatocellular carcinoma.

Authors:  Xiao-Yu Yin; Ming-De Lu; Ying-Rong Lai; Li-Jian Liang; Jie-Fu Huang
Journal:  Hepatogastroenterology       Date:  2003 Sep-Oct

2.  Phenotypic characterisation of the dendritic cell infiltrate in prostate cancer.

Authors:  A Troy; P Davidson; C Atkinson; D Hart
Journal:  J Urol       Date:  1998-07       Impact factor: 7.450

3.  Expression of platelet-derived endothelial cell growth factor and vascular endothelial growth factor in hepatocellular carcinoma and portal vein tumor thrombus.

Authors:  J Zhou; Z Y Tang; J Fan; Z Q Wu; X M Li; Y K Liu; F Liu; H C Sun; S L Ye
Journal:  J Cancer Res Clin Oncol       Date:  2000-01       Impact factor: 4.553

4.  Clinical significance of defective dendritic cell differentiation in cancer.

Authors:  B Almand; J R Resser; B Lindman; S Nadaf; J I Clark; E D Kwon; D P Carbone; D I Gabrilovich
Journal:  Clin Cancer Res       Date:  2000-05       Impact factor: 12.531

5.  Effect of vascular endothelial growth factor and FLT3 ligand on dendritic cell generation in vivo.

Authors:  J E Ohm; M R Shurin; C Esche; M T Lotze; D P Carbone; D I Gabrilovich
Journal:  J Immunol       Date:  1999-09-15       Impact factor: 5.422

Review 6.  Angiogenesis: how a tumor adapts to hypoxia.

Authors:  D E Richard; E Berra; J Pouysségur
Journal:  Biochem Biophys Res Commun       Date:  1999-12-29       Impact factor: 3.575

7.  Alpha-fetoprotein impairs APC function and induces their apoptosis.

Authors:  Soon Ho Um; Catherine Mulhall; Akeel Alisa; Annette Robyn Ives; John Karani; Roger Williams; Antonio Bertoletti; Shahriar Behboudi
Journal:  J Immunol       Date:  2004-08-01       Impact factor: 5.422

8.  Flt3 ligand-treated neonatal mice have increased innate immunity against intracellular pathogens and efficiently control virus infections.

Authors:  Sabine Vollstedt; Marco Franchini; Hans P Hefti; Bernhard Odermatt; Meredith O'Keeffe; Gottfried Alber; Bettina Glanzmann; Matthias Riesen; Mathias Ackermann; Mark Suter
Journal:  J Exp Med       Date:  2003-03-03       Impact factor: 14.307

9.  The CD8+ dendritic cell subset selectively endocytoses dying cells in culture and in vivo.

Authors:  Tomonori Iyoda; Susumu Shimoyama; Kang Liu; Yoshiki Omatsu; Yuji Akiyama; Yasuhiro Maeda; Kazuhiko Takahara; Ralph M Steinman; Kayo Inaba
Journal:  J Exp Med       Date:  2002-05-20       Impact factor: 14.307

  9 in total
  2 in total

Review 1.  The Changes of HIF-1α and VEGF Expression After TACE in Patients With Hepatocellular Carcinoma.

Authors:  Kang Liu; Xu-Li Min; Juan Peng; Ke Yang; Lin Yang; Xiao-Ming Zhang
Journal:  J Clin Med Res       Date:  2016-02-27

2.  Transcatheter hepatic arterial chemoembolization and sorafenib for hepatocellular carcinoma: a meta-analysis of randomized, double-blind controlled trials.

Authors:  Jun Li; Wenhui Liu; Wenhua Zhu; Yinqiao Wu; Benyan Wu
Journal:  Oncotarget       Date:  2017-07-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.